Exact Mass: 808.2464040000002
Exact Mass Matches: 808.2464040000002
Found 53 metabolites which its exact mass value is equals to given mass value 808.2464040000002
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Epimedin B
BaohuosideV
Baohuoside V is a natural product found in Epimedium sagittatum with data available.
Epmedin B
Epimedin B is a glycoside and a member of flavonoids. Epimedin B is a natural product found in Epimedium pubescens, Epimedium grandiflorum, and other organisms with data available. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1]. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1].
Epmedin
Epimedin B is a glycoside and a member of flavonoids. Epimedin B is a natural product found in Epimedium pubescens, Epimedium grandiflorum, and other organisms with data available. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1]. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1].
6)-glucoside]
Baohuoside V
8-Prenylkaempferol-3-4)rhamnoside>-7-glucoside (Rouhuoside)|8-Prenylkaempferol-3-[glucosyl(1->4)rhamnoside]-7-glucoside (Rouhuoside)
8-isoprenyl-rhamnocitrin-3-O-3)>-O-6)>-4-O-beta-D-glucopyranoside
5,7-dihydroxyphthalide 6-O-beta-{6-O-{3'-methoxy-4'-O-beta-[6'-O-(4'-O-carboxy-3',5'-dimethoxy)phenyl]glucopyranosyl}phenyl}glucopyranoside|rhamnakoside A
8-Prenylkaempferol-4-methylether-3-4)rhamnoside>-7-glucoside|8-Prenylkaempferol-4-methylether-3-[xylosyl(1->4)rhamnoside]-7-glucoside
8-Prenylkaempferol 3-rhamnosyl-(1->3)-[apiosyl-(1->6)-glucoside]
Epimedin B1
2-(3,4-dihydroxyphenyl)ethyl (5Z)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
Noranhydroicaritin 3-rhamnosyl-(1->3)-[apiosyl-(1->6)-glucoside]
tetrasodium,2-[[5-[1-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate
C38H40N2Na4O12 (808.2171920000001)
11-(Perfluorooctyl)undecyl dimorpholinophosphinate
Sodium 3-(3-carboxypropyl)-2-[3-(9-ethyl-6,8,8-trimethyl-2-phenyl-8,9-dihydropyrano[3,2-g]quinolin-1-ium-4-yl)prop-2-en-1-ylidene]-3-methyl-1-(3-sulfonatopropyl)indoline-5-sulfonate
C42H45N2NaO9S2 (808.2464040000002)
D004396 - Coloring Agents > D002232 - Carbocyanines
2-(3,4-dihydroxyphenyl)ethyl (5Z)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
Foxy-5 (TFA)
C28H43F3N6O14S2 (808.2230654000001)
Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1][2][3].